Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Mitigating Preeclampsia Risk May Reduce Preterm Birth, Cesarean Delivery

Mary Beth Nierengarten  |  Issue: December 2020  |  December 14, 2020

Mitigating Preeclampsia

“Of the three pregnancy complications we assessed, mitigating the risk of preeclampsia will do the most to reduce the risk of preterm birth and cesarean delivery in women with RA, SLE and psoriasis,” says Dr. Bandoli. “However, we would not expect it to have as much impact on those outcomes in women with IBD.”

For women with IBD, the study findings didn’t provide information on any pregnancy complications that may explain the excess risk of adverse pregnancy outcomes, according to Dr. Bandoli. “[This] suggests that either the disease directly affects the risk, instead of through pregnancy complications, or it’s operating through mediated pathways that we did not consider” she says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The data also do not suggest that interventions targeted at pregnancy infection or gestational diabetes will have much of an impact on reducing these select adverse birth outcomes in women with auto­immune disease, Dr. Bandoli says.


Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Bandoli G, Singh N, Strouse J, et al. Mediation of adverse pregnancy outcomes in autoimmune conditions by pregnancy complications: A mediation analysis of autoimmune conditions and adverse pregnancy outcomes. Arthritis Care Res (Hoboken). 2020 Feb;72(2):256–264.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:preeclampsiapregnancy

Related Articles

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Study Says Mothers’ Cardiovascular Health Is Linked to Pregnancy Outcomes in Lupus

    October 18, 2019

    A recent study in The Journal of Rheumatology sheds light on the importance of preconceptional cardiovascular health in women with systemic lupus erythematosus. Although many questions remain, improved cardiovascular health measures seem to positively affect pregnancy outcomes, suggesting a potential role for preconception cardiovascular interventions.1 Women with lupus now have healthier pregnancies than in the…

    Pregnancy Outcomes in Patients with Psoriatic Arthritis

    March 1, 2022

    In March A&R, Remaeus et al. reported on the results of their study, which evaluated pregnancy outcomes in relation to anti-rheumatic treatment before and during pregnancy, as a proxy of disease severity in pregnant women with psoriatic arthritis (PsA), compared with those without PsA.

    Treat to Target: Rheumatoid Arthritis in Pregnant Patients

    October 1, 2012

    A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences